Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Finn Wisløff

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|November 22, 2005
[Antineoplastic agents targeting tyrosine kinases]Tormod K Guren, Thoralf Christoffersen, G Hege Thoresen, et al.
Leukemia & Lymphoma|October 25, 2008
Impaired nutritional status during intensive chemotherapy in Russian and Norwegian cohorts with acute myeloid leukemiaPer Ole Iversen, Ekaterina Ukrainchenko, Boris Afanasyev, et al.
The Lancet. Oncology|September 25, 2010
Effect of pamidronate 30 mg versus 90 mg on physical function in patients with newly diagnosed multiple myeloma (Nordic Myeloma Study Group): a double-blind, randomised controlled trialPeter Gimsing, Kristina Carlson, Ingemar Turesson, et al.
Blood|May 8, 2010
Melphalan and prednisone plus thalidomide or placebo in elderly patients with multiple myelomaAnders Waage, Peter Gimsing, Peter Fayers, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|November 22, 2005
[Antineoplastic agents targeting tyrosine kinases]Tormod K Guren, Thoralf Christoffersen, G Hege Thoresen, et al.
Leukemia & Lymphoma|October 25, 2008
Impaired nutritional status during intensive chemotherapy in Russian and Norwegian cohorts with acute myeloid leukemiaPer Ole Iversen, Ekaterina Ukrainchenko, Boris Afanasyev, et al.
The Lancet. Oncology|September 25, 2010
Effect of pamidronate 30 mg versus 90 mg on physical function in patients with newly diagnosed multiple myeloma (Nordic Myeloma Study Group): a double-blind, randomised controlled trialPeter Gimsing, Kristina Carlson, Ingemar Turesson, et al.
Blood|May 8, 2010
Melphalan and prednisone plus thalidomide or placebo in elderly patients with multiple myelomaAnders Waage, Peter Gimsing, Peter Fayers, et al.
Pageof 3